CHAPTER 171
SB 557 - FINAL VERSION
2024 SESSION
24-3094
09/10
SENATE BILL 557
SPONSORS: Sen. Prentiss, Dist 5; Sen. Fenton, Dist 10; Sen. Watters, Dist 4; Sen. Rosenwald, Dist 13; Sen. Perkins Kwoka, Dist 21; Sen. Whitley, Dist 15; Sen. D'Allesandro, Dist 20; Rep. Hakken-Phillips, Graf. 12; Rep. Merchant, Sull. 6; Rep. J. Murphy, Graf. 12
COMMITTEE: Health and Human Services
─────────────────────────────────────────────────────────────────
ANALYSIS
This bill prohibits a health insurance issuer, pharmacy benefit manager, other third-party payer, or its agent from discriminating against an entity that participates in the federal 340B Drug Pricing Program based on the entity's participation in the program or that the drug is a drug covered by the program.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
24-3094
09/10
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Four
Be it Enacted by the Senate and House of Representatives in General Court convened:
171:1 New Section; Accident and Health Insurance; Participation in the Federal 340B Drug Pricing Program. Amend RSA 415 by inserting after section 15 the following new section:
415:15-a Discrimination Based on Participation in the Federal 340B Drug Pricing Program. Within the state of New Hampshire, for the reimbursement to covered entities enrolled in or eligible for the federal 340B Drug Pricing Program for covered drugs, as set forth in 42 U.S.C. section 256b, or such entities’ contract pharmacies to the extent such contract pharmacies are dispensing 340B drugs to 340B covered entities’ patients, a health insurance issuer, pharmacy benefit manager, other third-party payer, or its agent, shall not impose any terms or conditions, including, but not limited to, restrictions or requirements regarding participation in standard or preferred pharmacy networks or the imposition of a lower reimbursement amount for 340B covered drugs, on a covered entity or its contract pharmacy that differ from such terms or conditions that apply to any other entity on the basis that the entity participates in the federal 340B Drug Pricing Program or that the drug is a 340B covered drug.
171:2 Effective Date. This act shall take effect 60 days after its passage.
Approved: July 03, 2024
Effective Date: September 01, 2024
| Date | Body | Type |
|---|---|---|
| Feb. 21, 2024 | Senate | Hearing |
| March 7, 2024 | Senate | Floor Vote |
| April 30, 2024 | House | Hearing |
| May 15, 2024 | House | Exec Session |
| May 15, 2024 | House | Floor Vote |
July 10, 2024: Signed by the Governor on 07/03/2024; Chapter 0171; Effective 09/01/2024
June 24, 2024: Enrolled Adopted, VV, (In recess 06/13/2024); SJ 18
June 25, 2024: Enrolled (in recess of) 06/13/2024 HJ 16
June 24, 2024: Enrolled Adopted, VV, (In recess 06/13/2024); SJ 17
June 25, 2024: Enrolled (in recess of) 06/13/2024 HJ 16
May 23, 2024: Ought to Pass: MA VV 05/23/2024 HJ 14 P. 7
May 16, 2024: Committee Report: Ought to Pass 05/15/2024 (Vote 18-0; CC) HC 20 P. 8
May 8, 2024: Executive Session: 05/15/2024 10:00 am LOB 302-304
May 1, 2024: Work Session: 05/07/2024 01:15 pm LOB 302-304
April 9, 2024: Public Hearing: 04/30/2024 11:00 am LOB 302-304
March 12, 2024: Introduced 03/07/2024 and referred to Commerce and Consumer Affairs HJ 7 P. 110
March 7, 2024: Ought to Pass: MA, VV; OT3rdg; 03/07/2024; SJ 6
Feb. 22, 2024: Committee Report: Ought to Pass, 03/07/2024; Vote 5-0; CC; SC 9
Feb. 15, 2024: Hearing: 02/21/2024, Room 101, LOB, 09:45 am; SC 8
Dec. 14, 2023: To Be Introduced 01/03/2024 and Referred to Health and Human Services; SJ 1